Immune Response to Respiratory Viral Infections

Antonella Gambadauro,Francesca Galletta,Alessandra Li Pomi,Sara Manti,Giovanni Piedimonte
DOI: https://doi.org/10.3390/ijms25116178
IF: 5.6
2024-06-04
International Journal of Molecular Sciences
Abstract:The respiratory system is constantly exposed to viral infections that are responsible for mild to severe diseases. In this narrative review, we focalized the attention on respiratory syncytial virus (RSV), influenza virus, and severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infections, responsible for high morbidity and mortality in the last decades. We reviewed the human innate and adaptive immune responses in the airways following infection, focusing on a particular population: newborns and pregnant women. The recent Coronavirus disease-2019 (COVID-19) pandemic has highlighted how our interest in viral pathologies must not decrease. Furthermore, we must increase our knowledge of infection mechanisms to improve our future defense strategies.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to explore the specific impacts of respiratory virus infections (especially respiratory syncytial virus (RSV), influenza virus, and severe acute respiratory syndrome coronavirus 2 (SARS - CoV - 2)) on the human immune system, and summarize the immune responses of two special populations, neonates and pregnant women, after being infected with these viruses. By deeply understanding these immune response mechanisms, the author hopes to provide a theoretical basis for formulating more effective defense strategies in the future. ### Specific problems include: 1. **Immune response mechanisms of respiratory virus infections**: The paper elaborately describes the innate and adaptive immune responses of the human body to respiratory virus infections, including the roles of different types of immune cells (such as macrophages, dendritic cells, natural killer cells, etc.) and signal pathways (such as NF - κB, MAPK, TBK - 1/IRF3, etc.). 2. **Differences in immune responses of special populations**: Special attention is paid to these two groups, neonates and pregnant women, to explore the characteristics of their immune responses when infected with RSV, influenza virus, and SARS - CoV - 2. For example, the immune system of neonates has not fully developed, and the immune system of pregnant women will change during pregnancy, and these factors may all affect their responses to virus infections. 3. **Virus infection mechanisms and host escape mechanisms**: Compare the replication cycles, cellular targets of RSV, SARS - CoV - 2, and influenza virus during the infection process, and how they evade the recognition and attack of the host immune system. This helps to understand why these viruses can cause widespread respiratory diseases and provides clues for developing new treatment methods. 4. **The necessity of improving future defense strategies**: Through the review of existing literature, the importance of in - depth research on virus infection mechanisms is emphasized, especially in the context of the current COVID - 19 pandemic, to further enhance our prevention and control capabilities for future viral diseases. ### The core objectives of the paper are: - **Summarize high - quality research**: Provide a comprehensive overview by reviewing high - quality research on respiratory virus infections and their immune responses in recent years. - **Provide protection strategies for special populations**: Propose more effective prevention and treatment measures for these two susceptible groups, neonates and pregnant women. - **Promote future research directions**: Provide theoretical support for subsequent research, especially in terms of virus infection mechanisms and immune responses, with the expectation of developing better vaccines and drugs. By solving these problems, the paper aims to provide valuable references for the medical community and help improve the prevention and treatment strategies for respiratory virus infections, especially in high - risk populations.